Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -86.96% is 251% below its 5-year average of 57.54%, near the low end of its 5-year range (-86.96%–224.40%).
As of the fiscal period ended Wednesday, December 31, 2025. 213.03% below its 12-month average of -27.78%.
Annual fiscal-year return on equity; no daily interpolation. Historical series through 2025-12-31.
RETURN ON EQUITY (ROE)
-86.96%
RETURN ON EQUITY (ROE) AVG TTM
-27.78%
RETURN ON EQUITY (ROE) AVG 3Y
5.60%
RETURN ON EQUITY (ROE) AVG 5Y
57.54%
RETURN ON EQUITY (ROE) AVG 10Y
N/A
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-213.03%
CURRENT VS 3Y AVG
-1652.16%
CURRENT VS 5Y AVG
-251.13%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-39.44%
median of 550 covered companies
CURRENT VS SECTOR MEDIAN
-120.51%
vs the sector median at left
Baird Medical Investment Holdings Limited
Market Cap
$31.36M
Return on Equity (ROE)
-86.96%
TTM Avg
-27.78%
3Y Avg
5.60%
5Y Avg
57.54%
Market Cap
$31.36M
Return on Equity (ROE)
-116.14%
TTM Avg
-228.74%
3Y Avg
113.10%
5Y Avg
76.03%
Market Cap
$31.44M
Return on Equity (ROE)
2.91%
TTM Avg
-2.27%
3Y Avg
5.52%
5Y Avg
6.87%
Market Cap
$31.26M
Return on Equity (ROE)
N/A
TTM Avg
29.33%
3Y Avg
173.42%
5Y Avg
64.03%
Market Cap
$30.86M
Return on Equity (ROE)
N/A
TTM Avg
10.32%
3Y Avg
-262.53%
5Y Avg
-267.00%
Market Cap
$30.70M
Return on Equity (ROE)
-120.40%
TTM Avg
-43.89%
3Y Avg
-83.08%
5Y Avg
-65.54%
Market Cap
$30.28M
Return on Equity (ROE)
-132.18%
TTM Avg
-94.77%
3Y Avg
-38.62%
5Y Avg
-46.78%
Market Cap
$30.02M
Return on Equity (ROE)
-111.81%
TTM Avg
-29.10%
3Y Avg
-257.52%
5Y Avg
159.26%
Market Cap
$32.76M
Return on Equity (ROE)
N/A
TTM Avg
333.35%
3Y Avg
376.86%
5Y Avg
270.78%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Baird Medical Investment Holdings Limited (BDMD) | $31.36M | -86.96% | -27.78% | 5.60% | 57.54% |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $31.36M | -116.14% | -228.74% | 113.10% | 76.03% |
| Nortech Systems Incorporated (NSYS)vs › | $31.44M | 2.91% | -2.27% | 5.52% | 6.87% |
| BeyondSpring Inc. (BYSI)vs › | $31.26M | N/A | 29.33% | 173.42% | 64.03% |
| MDxHealth S.A. (MDXH)vs › | $30.86M | N/A | 10.32% | -262.53% | -267.00% |
| Context Therapeutics Inc. (CNTX)vs › | $30.70M | -120.40% | -43.89% | -83.08% | -65.54% |
| CervoMed Inc. (CRVO)vs › | $30.28M | -132.18% | -94.77% | -38.62% | -46.78% |
| GridAI Technologies Corp. (GRDX)vs › | $30.02M | -111.81% | -29.10% | -257.52% | 159.26% |
| EUDA Health Holdings Limited (EUDA)vs › | $32.76M | N/A | 333.35% | 376.86% | 270.78% |
| HeartBeam, Inc. (BEAT)vs › | $33.04M | -248.21% | -991.58% | -655.25% | -438.62% |
ROE
-87.0%
ROA
-39.1%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2025-12-31 | -86.96% |
| 2024-12-31 | 31.40% |
| 2023-12-31 | 29.50% |
| 2022-12-31 | 48.47% |
| 2021-12-31 | 224.40% |
| 2020-12-31 | 98.44% |
| 2019-12-31 | 32.82% |
